Cytokinetics Company Profile

00:09 EDT 18th March 2018 | BioPortfolio

Cytokinetics is focused on the complementary missions of drug discovery and the commercialization of novel cellular bioinformatics technologies. Cytokinetics drug discovery programs are exploiting the field of cytoskeletal pharmacology for the identification of entirely novel classes of therapeutic compounds. Cytokinetics cellular bioinformatics technologies, called Cytometrix™, are designed to increase the productivity and accelerate the speed of pharmaceutical discovery and development. Synergies generated by these two program areas have allowed Cytokinetics to move at a rapid pace toward the characterization of novel small molecule therapeutics.


280 East Grand Avenue, Suite #2
South San Francisco
United States of America


Phone: 650 624 3000
Fax: 650 624 3010

News Articles [30 Associated News Articles listed on BioPortfolio]

Cytokinetics crashes as it abandons ALS drug due to poor results

US biotech firm Cytokinetics saw its share price plummet 25.68% to $8.25, after the company revealed…

Cytokinetics To Announce Third Quarter Results On October 26, 2017

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is scheduled to report third quarter results on October 26, 2017 at 4...

STAT Plus: 7 things to know before Cytokinetics announces results from a pivotal drug study in ALS

ALS has proven stubbornly resistant to medicinal breakthroughs. Cytokinetics hopes to change that.

Cytokinetics ALS Drug Fails

. Cytokinetics, a biotechnology company, had hoped that by focusing on improving the function of muscle, not nerves, it could have an impact on lung function in patients with amyotrophic lateral scler...

Cytokinetics abandons ALS drug after failed trial

(Reuters) - Cytokinetics Inc said on Tuesday it would discontinue developing its drug to treat ALS, a fatal neuro-degenerative disorder, after the treatment failed in a late-stage trial.

Cytokinetics sinks on abandoning ALS drug after failed trial

(Reuters) - Cytokinetics Inc shares plummeted nearly 28 percent on Tuesday after the drugmaker said it would stop developing one of its treatments for ALS, a fatal neuro-degenerative disorder, after t...

Cytokinetics Pivots to Another ALS Drug After Phase 3 Failure

Cytokinetics’ bid to offer a new drug for amyotrophic lateral sclerosis (ALS) was dealt a setback after the company’s lead experimental treatment for the disease failed in a late-stage clinical tr...

Cytokinetics abandons ALS drug after failed trial, shares tank

(Reuters) - Cytokinetics Inc will stop developing one of its treatments for ALS, which afflicts Stephen Hawking, after the drug failed in a late-stage trial, the company said on Tuesday, sending its s...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Multiparameter cytometric analysis of complex cellular response.

Complex analysis of cellular responses after experimental treatment is important for screening, mechanistic understanding of treatment effects, and the identification of sensitive and resistant cell p...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma

A single arm, open-label pilot study is designed to determine the safety, efficacy and cytokinetics of CAR-BCMA T cells in patients with BCMA-positive refractory or relapsed multiple myelo...

A Study of SB-743921 in Non-Hodgkin's Lymphoma

Cytokinetics' CY 2121 Study is an early-phase trial arranged into two phases. The objectives of the first phase of the study are to assess the safety, tolerability and to identify the max...

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

A single arm, open-label pilot study is designed to determine the safety, efficacy and cytokinetics of CAR T cells in patients with malignant tumors with positive antigen targets. CAR T c...

Companies [0 Results]


More Information about "Cytokinetics" on BioPortfolio

We have published hundreds of Cytokinetics news stories on BioPortfolio along with dozens of Cytokinetics Clinical Trials and PubMed Articles about Cytokinetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cytokinetics Companies in our database. You can also find out about relevant Cytokinetics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record